M Pfeffer Selected Research

Cisplatin (Platino)

12/2005

Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Pfeffer Research Topics

Disease

5	Myocardial Infarction 08/2006 - 05/2000
4	Heart Failure 05/2007 - 01/2000
3	Stroke (Strokes) 05/2007 - 06/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 08/2006
2	Neoplasms (Cancer) 05/2014 - 12/2005
2	Infections 01/2014 - 07/2001
2	Inflammation (Inflammations) 08/2006 - 05/2000
2	Atrial Fibrillation 06/2006 - 06/2006
2	Hemorrhage 06/2006 - 10/2004
1	Lipedema 01/2021
1	Fibrosis (Cirrhosis) 10/2017
1	Chronic Renal Insufficiency 01/2016
1	Anemia 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 05/2013
1	Fever (Fevers) 04/2012
1	Coronary Disease (Coronary Heart Disease) 05/2007
1	Isolated Systolic Hypertension 08/2006
1	Hypertension (High Blood Pressure) 08/2006
1	Glioblastoma (Glioblastoma Multiforme) 12/2005
1	Neuroblastoma 12/2005
1	Acute Coronary Syndrome 10/2004
1	Ventricular Remodeling 12/2001
1	Anthrax 07/2001
1	Parasitic Diseases (Parasitic Disease) 01/2001
1	Hypotension (Low Blood Pressure) 06/2000
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2000
1	Ischemia 05/2000
1	Left Ventricular Dysfunction 05/2000
1	Infarction (Infarctions) 05/2000
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2000

Drug/Important Bio-Agent (IBA)

3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2006 - 06/2000
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2000 - 01/2000
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2000 - 01/2000
2	Peptides (Polypeptides)IBA 10/2017 - 12/2001
2	RutheniumIBA 05/2014 - 12/2005
2	Clopidogrel (Plavix)FDA Link 06/2006 - 06/2006
2	Irbesartan FDA LinkGeneric 06/2006 - 06/2006
2	candesartanIBA 06/2003 - 01/2000
1	Procollagen Type IIBA 10/2017
1	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2017
1	Darbepoetin alfa (Aranesp)FDA Link 01/2016
1	NucleotidesIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	AntibodiesIBA 04/2012
1	Pharmaceutical PreparationsIBA 05/2007
1	CholesterolIBA 08/2006
1	Coenzyme A (CoA)IBA 08/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2006
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2006
1	Oxidoreductases (Dehydrogenase)IBA 08/2006
1	AnticoagulantsIBA 06/2006
1	Organometallic CompoundsIBA 12/2005
1	Cytostatic AgentsIBA 12/2005
1	Cisplatin (Platino)FDA LinkGeneric 12/2005
1	Tirofiban (Aggrastat)FDA Link 10/2004
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2004
1	Heparin (Liquaemin)FDA LinkGeneric 10/2004
1	Natriuretic AgentsIBA 12/2001
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2001
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2001
1	N-terminal proatrial natriuretic peptideIBA 12/2001
1	EnzymesIBA 07/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2000
1	candesartan cilexetil (Amias)FDA Link 01/2000
1	Angiotensin IIIBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2016 - 05/2000
1	Ketogenic Diet 01/2021
1	Contraindications 06/2006
1	Intraperitoneal Injections 01/2001